{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:57Z","timestamp":1787020557729,"version":"build-2736575974"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Seventh Framework Programme","award":["607962"],"award-info":[{"award-number":["607962"]}]},{"name":"Seventh Framework Programme","award":["607962"],"award-info":[{"award-number":["607962"]}]},{"name":"Antti and Tyyne Soininen Foundation","award":["none"],"award-info":[{"award-number":["none"]}]},{"DOI":"10.13039\/501100004756","name":"Emil Aaltosen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["298071"],"award-info":[{"award-number":["298071"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ischemic stroke is a devastating disease without a cure. The available treatments for ischemic stroke, thrombolysis by tissue plasminogen activator, and thrombectomy are suitable only to a fraction of patients and thus novel therapeutic approaches are urgently needed. The neuroinflammatory responses elicited secondary to the ischemic attack further aggravate the stroke-induced neuronal damage. It has been demonstrated that these responses are regulated at the level of non-coding RNAs, especially miRNAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized lentiviral vectors to overexpress miR-669c in BV2 microglial cells in order to modulate their polarization. To detect whether the modulation of microglial activation by miR-669c provides protection in a mouse model of transient focal ischemic stroke, miR-669c overexpression was driven by a lentiviral vector injected into the striatum prior to induction of ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we demonstrate that miR-669c-3p, a member of chromosome 2 miRNA cluster (C2MC), is induced upon hypoxic and excitotoxic conditions in vitro and in two different in vivo models of stroke. Rather than directly regulating the neuronal survival in vitro, miR-669c is capable of attenuating the microglial proinflammatory activation in vitro and inducing the expression of microglial alternative activation markers arginase 1 (Arg1), chitinase-like 3 (Ym1), and peroxisome proliferator-activated receptor gamma (PPAR-\u03b3). Intracerebral overexpression of miR-669c significantly decreased the ischemia-induced cell death and ameliorated the stroke-induced neurological deficits both at 1 and 3\u2009days post injury (dpi). Albeit miR-669c overexpression failed to alter the overall Iba1 protein immunoreactivity, it significantly elevated Arg1 levels in the ischemic brain and increased colocalization of Arg1 and Iba1. Moreover, miR-669c overexpression under cerebral ischemia influenced several morphological characteristics of Iba1 positive cells. We further demonstrate the myeloid differentiation primary response gene 88 (MyD88) transcript as a direct target for miR-669c-3p in vitro and show reduced levels of MyD88 in miR-669c overexpressing ischemic brains in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our data provide the evidence that miR-669c-3p is protective in a mouse model of ischemic stroke through enhancement of the alternative microglial\/macrophage activation and inhibition of MyD88 signaling. Our results accentuate the importance of controlling miRNA-regulated responses for the therapeutic benefit in conditions of stroke and neuroinflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-020-01870-w","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T05:02:55Z","timestamp":1592542975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Intracerebral overexpression of miR-669c is protective in mouse ischemic stroke model by targeting MyD88 and inducing alternative microglial\/macrophage activation"],"prefix":"10.1186","volume":"17","author":[{"given":"Natalia","family":"Kolosowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gotkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiramani","family":"Dhungana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Giugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Box","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko T.","family":"Huuskonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Scoyni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M.","family":"Kanninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia A.","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko P.","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Koistinaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell."},{"key":"1870_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell."},{"key":"1870_CR3","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1073\/pnas.0707594105","volume":"105","author":"RF Place","year":"2008","unstructured":"Place RF, Li L-C, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A. 2008;105:1608\u201313. https:\/\/doi.org\/10.1073\/pnas.0707594105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1870_CR4","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1080\/15476286.2015.1112487","volume":"14","author":"M Xiao","year":"2017","unstructured":"Xiao M, Li J, Li W, et al. MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol. 2017;14:1326\u201334. https:\/\/doi.org\/10.1080\/15476286.2015.1112487.","journal-title":"RNA Biol"},{"key":"1870_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.4049\/jimmunol.1700196","volume":"200","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu W, Chen Y, et al. A cellular microRNA facilitates regulatory T lymphocyte development by targeting the FOXP3 promoter TATA-box motif. J Immunol. 2018;200:1053\u201363. https:\/\/doi.org\/10.4049\/jimmunol.1700196.","journal-title":"J Immunol"},{"key":"1870_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.nbd.2011.09.012","volume":"45","author":"Y-B Ouyang","year":"2012","unstructured":"Ouyang Y-B, Lu Y, Yue S, et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis. 2012;45:555\u201363. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.012.","journal-title":"Neurobiol Dis"},{"key":"1870_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2567.2011.03514.x","volume":"135","author":"AL Cardoso","year":"2012","unstructured":"Cardoso AL, Guedes JR, Pereira de Almeida L, Pedroso de Lima MC. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology. 2012;135:73\u201388. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03514.x.","journal-title":"Immunology"},{"key":"1870_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/STROKEAHA.114.007482","volume":"46","author":"P Liu","year":"2015","unstructured":"Liu P, Zhao H, Wang R, et al. MicroRNA-424 protects against focal cerebral ischemia and reperfusion injury in mice by suppressing oxidative stress. Stroke. 2015;46:513\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007482.","journal-title":"Stroke."},{"key":"1870_CR9","doi-asserted-by":"publisher","first-page":"13316","DOI":"10.1038\/srep13316","volume":"5","author":"Y Li","year":"2015","unstructured":"Li Y, Mao L, Gao Y, Baral S, Zhou Y, Hu B. MicroRNA-107 contributes to post-stroke angiogenesis by targeting Dicer-1. Sci Rep. 2015;5:13316. https:\/\/doi.org\/10.1038\/srep13316.","journal-title":"Sci Rep"},{"key":"1870_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2015.09.001","volume":"26","author":"AL Cardoso","year":"2016","unstructured":"Cardoso AL, Guedes JR, de Lima MCP. Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions. Curr Opin Pharmacol. 2016;26:1\u20139. https:\/\/doi.org\/10.1016\/j.coph.2015.09.001.","journal-title":"Curr Opin Pharmacol"},{"key":"1870_CR11","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/STROKEAHA.111.000504","volume":"44","author":"H Zhao","year":"2013","unstructured":"Zhao H, Wang J, Gao L, et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke. 2013;44:1706\u201313. https:\/\/doi.org\/10.1161\/STROKEAHA.111.000504.","journal-title":"Stroke."},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbi.2015.04.014","volume":"49","author":"J Ni","year":"2015","unstructured":"Ni J, Wang X, Chen S, et al. MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain Behav Immun. 2015;49:75\u201385. https:\/\/doi.org\/10.1016\/j.bbi.2015.04.014.","journal-title":"Brain Behav Immun"},{"key":"1870_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11481-016-9700-y","volume":"11","author":"S Hamzei Taj","year":"2016","unstructured":"Hamzei Taj S, Kho W, Aswendt M, et al. Dynamic modulation of microglia\/macrophage polarization by miR-124 after focal cerebral ischemia. J NeuroImmune Pharmacol. 2016;11:733\u201348. https:\/\/doi.org\/10.1007\/s11481-016-9700-y.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1870_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2014.11.007","volume":"264","author":"L-J Xu","year":"2015","unstructured":"Xu L-J, Ouyang Y-B, Xiong X, Stary CM, Giffard RG. Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia. Exp Neurol. 2015;264:1\u20137. https:\/\/doi.org\/10.1016\/j.expneurol.2014.11.007.","journal-title":"Exp Neurol"},{"key":"1870_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biomaterials.2016.03.025","volume":"91","author":"S Hamzei Taj","year":"2016","unstructured":"Hamzei Taj S, Kho W, Riou A, Wiedermann D, Hoehn M. MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia. Biomaterials. 2016;91:151\u201365. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.03.025.","journal-title":"Biomaterials."},{"key":"1870_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/1471-2164-12-257","volume":"12","author":"S Lehnert","year":"2011","unstructured":"Lehnert S, Kapitonov V, Thilakarathne PJ, Schuit FC. Modeling the asymmetric evolution of a mouse and rat-specific microRNA gene cluster intron 10 of the Sfmbt2 gene. BMC Genomics. 2011;12:257. https:\/\/doi.org\/10.1186\/1471-2164-12-257.","journal-title":"BMC Genomics"},{"key":"1870_CR17","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/bit.23092","volume":"108","author":"A Druz","year":"2011","unstructured":"Druz A, Chu C, Majors B, Santuary R, Betenbaugh M, Shiloach J. A novel microRNA mmu-miR-466\u2009h affects apoptosis regulation in mammalian cells. Biotechnol Bioeng. 2011;108:1651\u201361. https:\/\/doi.org\/10.1002\/bit.23092.","journal-title":"Biotechnol Bioeng"},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1093\/nar\/gks452","volume":"40","author":"A Druz","year":"2012","unstructured":"Druz A, Betenbaugh M, Shiloach J. Glucose depletion activates mmu-miR-466\u2009h-5p expression through oxidative stress and inhibition of histone deacetylation. Nucleic Acids Res. 2012;40:7291\u2013302. https:\/\/doi.org\/10.1093\/nar\/gks452.","journal-title":"Nucleic Acids Res"},{"key":"1870_CR19","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1073\/pnas.0813371106","volume":"106","author":"K Wang","year":"2009","unstructured":"Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106:4402\u20137. https:\/\/doi.org\/10.1073\/pnas.0813371106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1870_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.mad.2008.05.004","volume":"129","author":"OC Maes","year":"2008","unstructured":"Maes OC, An J, Sarojini H, Wang E. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev. 2008;129:534\u201341. https:\/\/doi.org\/10.1016\/j.mad.2008.05.004.","journal-title":"Mech Ageing Dev"},{"key":"1870_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/toxsci\/kfx241","volume":"162","author":"J-T Liu","year":"2018","unstructured":"Liu J-T, Bain LJ. Arsenic induces members of the mmu-miR-466-669 cluster which reduces neuroD1 expression. Toxicol Sci. 2018;162:64\u201378. https:\/\/doi.org\/10.1093\/toxsci\/kfx241.","journal-title":"Toxicol Sci"},{"key":"1870_CR22","first-page":"316","volume":"4","author":"JG Hunsberger","year":"2012","unstructured":"Hunsberger JG, Fessler EB, Wang Z, Elkahloun AG, Chuang D-M. Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am J Transl Res. 2012;4:316\u201332.","journal-title":"Am J Transl Res"},{"key":"1870_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12974-014-0229-9","volume":"12","author":"T Malm","year":"2015","unstructured":"Malm T, Mariani M, Donovan LJ, Neilson L, Landreth GE. Activation of the nuclear receptor PPAR\u03b4 is neuroprotective in a transgenic mouse model of Alzheimer\u2019s disease through inhibition of inflammation. J Neuroinflammation. 2015;12:7. https:\/\/doi.org\/10.1186\/s12974-014-0229-9.","journal-title":"J Neuroinflammation"},{"key":"1870_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jgm.860","volume":"8","author":"PI M\u00e4kinen","year":"2006","unstructured":"M\u00e4kinen PI, Koponen JK, K\u00e4rkk\u00e4inen A-M, et al. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med. 2006;8:433\u201341. https:\/\/doi.org\/10.1002\/jgm.860.","journal-title":"J Gene Med"},{"key":"1870_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/acel.12106","volume":"12","author":"H Dhungana","year":"2013","unstructured":"Dhungana H, Malm T, Denes A, et al. Aging aggravates ischemic stroke-induced brain damage in mice with chronic peripheral infection. Aging Cell. 2013;12:842\u201350. https:\/\/doi.org\/10.1111\/acel.12106.","journal-title":"Aging Cell"},{"key":"1870_CR26","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1523\/JNEUROSCI.1227-10.2010","volume":"30","author":"A Denes","year":"2010","unstructured":"Denes A, Humphreys N, Lane TE, Grencis R, Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J Neurosci. 2010;30:10086\u201395. https:\/\/doi.org\/10.1523\/JNEUROSCI.1227-10.2010.","journal-title":"J Neurosci"},{"key":"1870_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/01616412.1997.11740874","volume":"19","author":"WM Clark","year":"1997","unstructured":"Clark WM, Lessov NS, Dixon MP, Eckenstein F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res. 1997;19:641\u20138.","journal-title":"Neurol Res"},{"key":"1870_CR28","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1161\/01.STR.0000039405.31526.06","volume":"33","author":"A Shuaib","year":"2002","unstructured":"Shuaib A, Xu Wang C, Yang T, Noor R. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke. 2002;33:3033\u20137.","journal-title":"Stroke."},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordeli\u00e8res FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224:213\u201332. https:\/\/doi.org\/10.1111\/j.1365-2818.2006.01706.x.","journal-title":"J Microsc"},{"key":"1870_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.neuroscience.2015.09.061","volume":"310","author":"R Kongsui","year":"2015","unstructured":"Kongsui R, Johnson SJ, Graham BA, Nilsson M, Walker FR. A combined cumulative threshold spectra and digital reconstruction analysis reveal structural alterations of microglia within the prefrontal cortex following low-dose LPS administration. Neuroscience. 2015;310:629\u201340. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.09.061.","journal-title":"Neuroscience."},{"key":"1870_CR31","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, Shrestha S, Yang CD, et al. MiRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46:D296\u2013302. https:\/\/doi.org\/10.1093\/nar\/gkx1067.","journal-title":"Nucleic Acids Res"},{"key":"1870_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson A, Farh KKH, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91\u2013105. https:\/\/doi.org\/10.1016\/j.molcel.2007.06.017.","journal-title":"Mol Cell"},{"key":"1870_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320. https:\/\/doi.org\/10.1016\/j.cell.2004.12.035.","journal-title":"Cell"},{"key":"1870_CR34","doi-asserted-by":"publisher","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. https:\/\/doi.org\/10.7554\/eLife.05005.","DOI":"10.7554\/eLife.05005"},{"key":"1870_CR35","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"key":"1870_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/c5mb00663e","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He QY. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol BioSyst. 2016;12:477\u20139. https:\/\/doi.org\/10.1039\/c5mb00663e.","journal-title":"Mol BioSyst"},{"key":"1870_CR37","doi-asserted-by":"publisher","unstructured":"Wani S, Cloonan N. Profiling direct mRNA-microRNA interactions using synthetic biotinylated microRNA-duplexes. bioRxiv. 2014:005439. https:\/\/doi.org\/10.1101\/005439.","DOI":"10.1101\/005439"},{"key":"1870_CR38","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","volume":"32","author":"D Ito","year":"2001","unstructured":"Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke. 2001;32:1208\u201315.","journal-title":"Stroke."},{"key":"1870_CR39","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/ejn.12111","volume":"37","author":"A Quiri\u00e9","year":"2013","unstructured":"Quiri\u00e9 A, Demougeot C, Bertrand N, et al. Effect of stroke on arginase expression and localization in the rat brain. Eur J Neurosci. 2013;37:1193\u2013202. https:\/\/doi.org\/10.1111\/ejn.12111.","journal-title":"Eur J Neurosci"},{"key":"1870_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/J.BBI.2018.07.021","volume":"73","author":"S Loppi","year":"2018","unstructured":"Loppi S, Kolosowska N, K\u00e4rkk\u00e4inen O, et al. HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage. Brain Behav Immun. 2018;73:670\u201381. https:\/\/doi.org\/10.1016\/J.BBI.2018.07.021.","journal-title":"Brain Behav Immun"},{"key":"1870_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2017.13.1.1","volume":"13","author":"S Vidale","year":"2017","unstructured":"Vidale S, Consoli A, Arnaboldi M, Consoli D. Postischemic inflammation in acute stroke. J Clin Neurol. 2017;13:1. https:\/\/doi.org\/10.3988\/jcn.2017.13.1.1.","journal-title":"J Clin Neurol"},{"key":"1870_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbi.2015.06.013","volume":"49","author":"P Korhonen","year":"2015","unstructured":"Korhonen P, Kanninen KM, Lehtonen \u0160, et al. Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation. Brain Behav Immun. 2015;49:322\u201336. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.013.","journal-title":"Brain Behav Immun"},{"key":"1870_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/STROKEAHA.114.006864","volume":"46","author":"C Brifault","year":"2015","unstructured":"Brifault C, Gras M, Liot D, May V, Vaudry D, Wurtz O. Delayed pituitary adenylate cyclase\u2013activating polypeptide delivery after brain stroke improves functional recovery by inducing M2 microglia\/macrophage polarization. Stroke. 2015;46:520\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006864.","journal-title":"Stroke."},{"key":"1870_CR44","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/glia.23017","volume":"64","author":"S Lemarchant","year":"2016","unstructured":"Lemarchant S, Dunghana H, Pomeshchik Y, et al. Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke. Glia. 2016;64:1492\u2013507. https:\/\/doi.org\/10.1002\/glia.23017.","journal-title":"Glia."},{"key":"1870_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.expneurol.2015.10.012","volume":"275","author":"D Amantea","year":"2016","unstructured":"Amantea D, Certo M, Petrelli F, et al. Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype. Exp Neurol. 2016;275:116\u201325. https:\/\/doi.org\/10.1016\/j.expneurol.2015.10.012.","journal-title":"Exp Neurol"},{"issue":"Pt 1","key":"1870_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3360001","volume":"336","author":"G Wu","year":"1998","unstructured":"Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1\u201317.","journal-title":"Biochem J"},{"key":"1870_CR47","doi-asserted-by":"publisher","first-page":"2021S","DOI":"10.1093\/jn\/138.10.2021S","volume":"138","author":"A Barbul","year":"2008","unstructured":"Barbul A. Proline precursors to sustain mammalian collagen synthesis. J Nutr. 2008;138:2021S\u20134S. https:\/\/doi.org\/10.1093\/jn\/138.10.2021S.","journal-title":"J Nutr"},{"key":"1870_CR48","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","volume":"158","author":"M Munder","year":"2009","unstructured":"Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol. 2009;158:638\u201351. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00291.x.","journal-title":"Br J Pharmacol"},{"key":"1870_CR49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0896-6273(02)00826-7","volume":"35","author":"D Cai","year":"2002","unstructured":"Cai D, Deng K, Mellado W, Lee J, Ratan RR, Filbin MT. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 2002;35:711\u20139.","journal-title":"Neuron."},{"key":"1870_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.expneurol.2017.08.011","volume":"301","author":"JG Zarruk","year":"2018","unstructured":"Zarruk JG, Greenhalgh AD, David S. Microglia and macrophages differ in their inflammatory profile after permanent brain ischemia. Exp Neurol. 2018;301:120\u201332. https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.011.","journal-title":"Exp Neurol"},{"key":"1870_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.nbd.2016.09.017","volume":"96","author":"C Perego","year":"2016","unstructured":"Perego C, Fumagalli S, Zanier ER, et al. Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury. Neurobiol Dis. 2016;96:284\u201393. https:\/\/doi.org\/10.1016\/j.nbd.2016.09.017.","journal-title":"Neurobiol Dis"},{"key":"1870_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12974-015-0329-1","volume":"12","author":"RM Ritzel","year":"2015","unstructured":"Ritzel RM, Patel AR, Grenier JM, et al. Functional differences between microglia and monocytes after ischemic stroke. J Neuroinflammation. 2015;12:106. https:\/\/doi.org\/10.1186\/s12974-015-0329-1.","journal-title":"J Neuroinflammation"},{"key":"1870_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.PNEUROBIO.2017.08.002","volume":"163\u2013164","author":"G Li","year":"2018","unstructured":"Li G, Morris-Blanco KC, Lopez MS, et al. Impact of microRNAs on ischemic stroke: from pre- to post-disease. Prog Neurobiol. 2018;163\u2013164:59\u201378. https:\/\/doi.org\/10.1016\/J.PNEUROBIO.2017.08.002.","journal-title":"Prog Neurobiol"},{"key":"1870_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jcb.24960","volume":"116","author":"H Yu","year":"2015","unstructured":"Yu H, Wu M, Zhao P, Huang Y, Wang W, Yin W. Neuroprotective effects of viral overexpression of microRNA-22 in rat and cell models of cerebral ischemia-reperfusion injury. J Cell Biochem. 2015;116:233\u201341. https:\/\/doi.org\/10.1002\/jcb.24960.","journal-title":"J Cell Biochem"},{"key":"1870_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.molimm.2015.01.019","volume":"65","author":"Z Yang","year":"2015","unstructured":"Yang Z, Zhong L, Zhong S, Xian R, Yuan B. miR-203 protects microglia mediated brain injury by regulating inflammatory responses via feedback to MyD88 in ischemia. Mol Immunol. 2015;65:293\u2013301. https:\/\/doi.org\/10.1016\/j.molimm.2015.01.019.","journal-title":"Mol Immunol"},{"key":"1870_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41419-017-0014-7","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Chen S, Ni J, Cheng J, Jia J, Zhen X. miRNA-3473b contributes to neuroinflammation following cerebral ischemia. Cell Death Dis. 2018;9:11. https:\/\/doi.org\/10.1038\/s41419-017-0014-7.","journal-title":"Cell Death Dis"},{"key":"1870_CR57","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1523\/JNEUROSCI.1240-15.2016","volume":"36","author":"NJ Kuypers","year":"2016","unstructured":"Kuypers NJ, Bankston AN, Howard RM, Beare JE, Whittemore SR. Remyelinating oligodendrocyte precursor cell miRNAs from the Sfmbt2 cluster promote cell cycle arrest and differentiation. J Neurosci. 2016;36:1698\u2013710. https:\/\/doi.org\/10.1523\/JNEUROSCI.1240-15.2016.","journal-title":"J Neurosci"},{"key":"1870_CR58","doi-asserted-by":"publisher","first-page":"86535","DOI":"10.18632\/oncotarget.21238","volume":"8","author":"C Liu","year":"2017","unstructured":"Liu C, Zhang C, Yang J, et al. Screening circular RNA expression patterns following focal cerebral ischemia in mice. Oncotarget. 2017;8:86535\u201347. https:\/\/doi.org\/10.18632\/oncotarget.21238.","journal-title":"Oncotarget"},{"key":"1870_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-014-0211-6","volume":"11","author":"G Pepe","year":"2014","unstructured":"Pepe G, Calderazzi G, De Maglie M, Villa AM, Vegeto E. Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4. J Neuroinflammation. 2014;11:211. https:\/\/doi.org\/10.1186\/s12974-014-0211-6.","journal-title":"J Neuroinflammation"},{"key":"1870_CR60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41419-018-0288-4","volume":"9","author":"C Rossi","year":"2018","unstructured":"Rossi C, Cusimano M, Zambito M, et al. Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis. Cell Death Dis. 2018;9:250. https:\/\/doi.org\/10.1038\/s41419-018-0288-4.","journal-title":"Cell Death Dis"},{"key":"1870_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1742-2094-8-174","volume":"8","author":"C Perego","year":"2011","unstructured":"Perego C, Fumagalli S. Simoni M-G De. Temporal pattern of expression and colocalization of microglia\/macrophage phenotype markers following brain ischemic injury in mice J Neuroinflammation. 2011;8:174. https:\/\/doi.org\/10.1186\/1742-2094-8-174.","journal-title":"Temporal pattern of expression and colocalization of microglia\/macrophage phenotype markers following brain ischemic injury in mice J Neuroinflammation"},{"key":"1870_CR62","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1471-4159.2006.03758.x","volume":"97","author":"Y Luo","year":"2006","unstructured":"Luo Y, Yin W, Signore AP, et al. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone. J Neurochem. 2006;97:435\u201348. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03758.x.","journal-title":"J Neurochem"},{"key":"1870_CR63","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","volume":"32","author":"S Mandrekar-Colucci","year":"2012","unstructured":"Mandrekar-Colucci S, Karlo JC, Landreth GE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-\u03b3-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease. J Neurosci. 2012;32:10117\u201328. https:\/\/doi.org\/10.1523\/JNEUROSCI.5268-11.2012.","journal-title":"J Neurosci"},{"key":"1870_CR64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbrc.2012.08.039","volume":"426","author":"M Hasegawa-Moriyama","year":"2012","unstructured":"Hasegawa-Moriyama M, Ohnou T, Godai K, Kurimoto T, Nakama M, Kanmura Y. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization. Biochem Biophys Res Commun. 2012;426:76\u201382. https:\/\/doi.org\/10.1016\/j.bbrc.2012.08.039.","journal-title":"Biochem Biophys Res Commun"},{"key":"1870_CR65","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","volume":"71","author":"A Pisanu","year":"2014","unstructured":"Pisanu A, Lecca D, Mulas G, et al. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease. Neurobiol Dis. 2014;71:280\u201391. https:\/\/doi.org\/10.1016\/j.nbd.2014.08.011.","journal-title":"Neurobiol Dis"},{"key":"1870_CR66","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature05894","volume":"447","author":"JI Odegaard","year":"2007","unstructured":"Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007;447:1116\u201320. https:\/\/doi.org\/10.1038\/nature05894.","journal-title":"Nature."},{"key":"1870_CR67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12035-013-8538-z","volume":"49","author":"M Chaturvedi","year":"2014","unstructured":"Chaturvedi M, Kaczmarek L. Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol. 2014;49:563\u201373. https:\/\/doi.org\/10.1007\/s12035-013-8538-z.","journal-title":"Mol Neurobiol"},{"key":"1870_CR68","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","volume":"32","author":"KL Lambertsen","year":"2012","unstructured":"Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012;32:1677\u201398. https:\/\/doi.org\/10.1038\/jcbfm.2012.88.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1870_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499\u2013511. https:\/\/doi.org\/10.1038\/nri1391.","journal-title":"Nat Rev Immunol"},{"key":"1870_CR70","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ni1308","volume":"7","author":"D Sun","year":"2006","unstructured":"Sun D, Ding A. MyD88-mediated stabilization of interferon-\u03b3-induced cytokine and chemokine mRNA. Nat Immunol. 2006;7:375\u201381. https:\/\/doi.org\/10.1038\/ni1308.","journal-title":"Nat Immunol"},{"key":"1870_CR71","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.106.603431","volume":"115","author":"JR Caso","year":"2007","unstructured":"Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 2007;115:1599\u2013608. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.603431.","journal-title":"Circulation."},{"key":"1870_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nbd.2008.03.002","volume":"31","author":"U Kilic","year":"2008","unstructured":"Kilic U, Kilic E, Matter CM, Bassetti CL, Hermann DM. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol Dis. 2008;31:33\u201340. https:\/\/doi.org\/10.1016\/j.nbd.2008.03.002.","journal-title":"Neurobiol Dis"},{"key":"1870_CR73","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/jcbfm.2008.50","volume":"28","author":"Q Yang","year":"2008","unstructured":"Yang Q, Li J, Lu F, et al. Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab. 2008;28:1588\u201396. https:\/\/doi.org\/10.1038\/jcbfm.2008.50.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1870_CR74","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/1753425910374092","volume":"17","author":"TL Kissner","year":"2011","unstructured":"Kissner TL, Ruthel G, Cisney ED, Ulrich RG, Fernandez S, Saikh KU. MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice. Innate Immun. 2011;17:451\u201362. https:\/\/doi.org\/10.1177\/1753425910374092.","journal-title":"Innate Immun"},{"key":"1870_CR75","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.4049\/JIMMUNOL.181.9.6481","volume":"181","author":"AA Babcock","year":"2008","unstructured":"Babcock AA, Toft-Hansen H, Owens T. Signaling through MyD88 regulates leukocyte recruitment after brain injury. J Immunol. 2008;181:6481\u201390. https:\/\/doi.org\/10.4049\/JIMMUNOL.181.9.6481.","journal-title":"J Immunol"},{"key":"1870_CR76","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1159\/000490866","volume":"47","author":"Q Su","year":"2018","unstructured":"Su Q, Li L, Sun Y, Yang H, Ye Z, Zhao J. Effects of the TLR4\/Myd88\/NF-\u03baB signaling pathway on NLRP3 inflammasome in coronary microembolization-induced myocardial injury. Cell Physiol Biochem. 2018;47:1497\u2013508. https:\/\/doi.org\/10.1159\/000490866.","journal-title":"Cell Physiol Biochem"},{"key":"1870_CR77","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI26078","volume":"116","author":"M Prinz","year":"2006","unstructured":"Prinz M, Garbe F, Schmidt H, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest. 2006;116:456\u201364. https:\/\/doi.org\/10.1172\/JCI26078.","journal-title":"J Clin Invest"},{"key":"1870_CR78","doi-asserted-by":"publisher","first-page":"28188","DOI":"10.1038\/srep28188","volume":"6","author":"X-J Liu","year":"2016","unstructured":"Liu X-J, Liu T, Chen G, et al. TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation. Sci Rep. 2016;6:28188. https:\/\/doi.org\/10.1038\/srep28188.","journal-title":"Sci Rep"},{"key":"1870_CR79","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2353\/ajpath.2007.060821","volume":"171","author":"U Koedel","year":"2007","unstructured":"Koedel U, Merbt UM, Schmidt C, et al. Acute brain injury triggers MyD88-dependent, TLR2\/4-independent inflammatory responses. Am J Pathol. 2007;171:200\u201313. https:\/\/doi.org\/10.2353\/ajpath.2007.060821.","journal-title":"Am J Pathol"},{"key":"1870_CR80","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/J.BRAINRES.2016.05.003","volume":"2016","author":"H-S Zhang","year":"1643","unstructured":"Zhang H-S, Li H, Zhang D-D, et al. Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice. Brain Res. 1643;2016:130\u20139. https:\/\/doi.org\/10.1016\/J.BRAINRES.2016.05.003.","journal-title":"Brain Res"},{"key":"1870_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.expneurol.2017.05.008","volume":"295","author":"N Wang","year":"2017","unstructured":"Wang N, Han X, Liu H, et al. Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats. Exp Neurol. 2017;295:23\u201335. https:\/\/doi.org\/10.1016\/j.expneurol.2017.05.008.","journal-title":"Exp Neurol"},{"key":"1870_CR82","doi-asserted-by":"publisher","unstructured":"Liu J-T, Wu S-X, Zhang H, Kuang F. Inhibition of MyD88 signaling skews microglia\/macrophage polarization and attenuates neuronal apoptosis in the hippocampus after status epilepticus in mice. Neurotherapeutics. 2018:1\u201319. https:\/\/doi.org\/10.1007\/s13311-018-0653-0.","DOI":"10.1007\/s13311-018-0653-0"},{"key":"1870_CR83","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1172\/JCI96209","volume":"128","author":"SB Rangasamy","year":"2018","unstructured":"Rangasamy SB, Jana M, Roy A, et al. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer\u2019s pathology. J Clin Investig. 2018;128:4297\u2013312. https:\/\/doi.org\/10.1172\/JCI96209.","journal-title":"J Clin Investig"},{"key":"1870_CR84","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.4049\/jimmunol.0900762","volume":"183","author":"X Wang","year":"2009","unstructured":"Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol. 2009;183:7471\u20137. https:\/\/doi.org\/10.4049\/jimmunol.0900762.","journal-title":"J Immunol"},{"key":"1870_CR85","doi-asserted-by":"publisher","first-page":"15797","DOI":"10.1038\/s41598-017-16124-8","volume":"7","author":"H Yan","year":"2017","unstructured":"Yan H, Zhang D, Wei Y, et al. Inhibition of myeloid differentiation primary response protein 88 provides neuroprotection in early brain injury following experimental subarachnoid hemorrhage. Sci Rep. 2017;7:15797. https:\/\/doi.org\/10.1038\/s41598-017-16124-8.","journal-title":"Sci Rep"},{"key":"1870_CR86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.BBRC.2016.10.007","volume":"480","author":"X Ye","year":"2016","unstructured":"Ye X, Kong D, Wang J, et al. MyD88 contributes to neuroinflammatory responses induced by cerebral ischemia\/reperfusion in mice. Biochem Biophys Res Commun. 2016;480:69\u201374. https:\/\/doi.org\/10.1016\/J.BBRC.2016.10.007.","journal-title":"Biochem Biophys Res Commun"},{"key":"1870_CR87","doi-asserted-by":"publisher","first-page":"80315","DOI":"10.18632\/oncotarget.20699","volume":"8","author":"L-R Wu","year":"2017","unstructured":"Wu L-R, Liu L, Xiong X-Y, et al. Vinpocetine alleviate cerebral ischemia\/reperfusion injury by down-regulating TLR4\/MyD88\/NF-\u03baB signaling. Oncotarget. 2017;8:80315\u201324. https:\/\/doi.org\/10.18632\/oncotarget.20699.","journal-title":"Oncotarget"},{"key":"1870_CR88","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainres.2011.02.074","volume":"1388","author":"BM Famakin","year":"2011","unstructured":"Famakin BM, Mou Y, Ruetzler CA, Bembry J, Maric D, Hallenbeck JM. Disruption of downstream MyD88 or TRIF toll-like receptor signaling does not protect against cerebral ischemia. Brain Res. 2011;1388:148\u201356. https:\/\/doi.org\/10.1016\/j.brainres.2011.02.074.","journal-title":"Brain Res"},{"key":"1870_CR89","doi-asserted-by":"publisher","unstructured":"Downes CE, Wong CHY, Henley KJ, et al. MyD88 Is a critical regulator of hematopoietic cell-mediated neuroprotection seen after stroke. Arumugam T V., editor. PLoS One. 2013; 8:e57948. doi: https:\/\/doi.org\/10.1371\/journal.pone.0057948.","DOI":"10.1371\/journal.pone.0057948"},{"key":"1870_CR90","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1084\/jem.21213insight1","volume":"212","author":"R K\u00fcppers","year":"2015","unstructured":"K\u00fcppers R. IRAK4 inhibition to shut down TLR signaling in autoimmunity and MyD88-dependent lymphomas. J Exp Med. 2015;212:2184. https:\/\/doi.org\/10.1084\/jem.21213insight1.","journal-title":"J Exp Med"},{"key":"1870_CR91","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314\u20138. https:\/\/doi.org\/10.1126\/science.1110647.","journal-title":"Science."},{"key":"1870_CR92","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","volume":"19","author":"GW Kreutzberg","year":"1996","unstructured":"Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312\u20138.","journal-title":"Trends Neurosci"},{"key":"1870_CR93","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/stem.1409","volume":"31","author":"H Xin","year":"2013","unstructured":"Xin H, Li Y, Liu Z, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31:2737\u201346. https:\/\/doi.org\/10.1002\/stem.1409.","journal-title":"Stem Cells"},{"key":"1870_CR94","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1159\/000490078","volume":"47","author":"M Jiang","year":"2018","unstructured":"Jiang M, Wang H, Jin M, et al. Exosomes from MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial\/macrophage polarization. Cell Physiol Biochem. 2018;47:864\u201378. https:\/\/doi.org\/10.1159\/000490078.","journal-title":"Cell Physiol Biochem"},{"key":"1870_CR95","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/STROKEAHA.117.018292","volume":"49","author":"J Chen","year":"2018","unstructured":"Chen J, Chopp M. Exosome therapy for stroke. Stroke. 2018;49:1083\u201390. https:\/\/doi.org\/10.1161\/STROKEAHA.117.018292.","journal-title":"Stroke."},{"key":"1870_CR96","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12974-017-0991-6","volume":"14","author":"H Martiskainen","year":"2017","unstructured":"Martiskainen H, Paldanius KMA, Natunen T, et al. DHCR24 exerts neuroprotection upon inflammation-induced neuronal death. J Neuroinflammation. 2017;14:215. https:\/\/doi.org\/10.1186\/s12974-017-0991-6.","journal-title":"J Neuroinflammation"},{"key":"1870_CR97","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","volume":"7","author":"J Yang","year":"2017","unstructured":"Yang J, Zhang X, Chen X, Wang L, Yang G. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids. 2017;7:278\u201387. https:\/\/doi.org\/10.1016\/j.omtn.2017.04.010.","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01870-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-020-01870-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01870-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T19:39:30Z","timestamp":1624045170000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01870-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01870-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"30 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All of the experiments followed the Helsinki Declaration and the European Commission guidelines (European Communities Council Directive, 86\/609\/EEC). We have the permission and valid license for performing the animal models of stroke (R-ESAVI-2018-012284-TM). Primary microglia and cortical neurons cultures in vitro were prepared under the license for cell culture and tissue models of neurodegenerative brain diseases (EKS-009-2016). The in vitro and in vivo experiments with lentiviral vectors were carried out under a permission (033\/M\/2009) from the Finnish National Supervisory Authority for Welfare and Health, Valvira.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}